Upregulation of peroxisome proliferator-activated receptor-γ and NADPH oxidases are involved in restenosis after balloon injury

Journal of Cellular Physiology

Volumn 221, Issue 2, 2009, Pages 387-393

  Qin, Hai Dong ^a   Dan, Huang ^b   Weng, Xiao Dan ^c   Feng, Xu ^d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Nantong College   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; GLYCOPROTEIN GP 91; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; DRUG DERIVATIVE; PROSTAGLANDIN D2; PROTEIN SUBUNIT;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BALLOON INJURY; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; ENZYME ACTIVITY; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INJURY; INTIMA; MOLECULE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SWINE; ANIMAL; CORONARY BLOOD VESSEL; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; UPREGULATION;

SUS;

ANGIOPLASTY, BALLOON; ANIMALS; CELL PROLIFERATION; CORONARY RESTENOSIS; CORONARY VESSELS; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; OXIDATIVE STRESS; PPAR GAMMA; PROSTAGLANDIN D2; PROTEIN SUBUNITS; SUPEROXIDES; SUS SCROFA; UP-REGULATION;

EID: 70149111780     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21865     Document Type: Article

References (46)

1. Aizawa Y, Kawabe J, Hasebe N, Takehara N, Kikuchi K. 2001. Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia. Circulation 104:455-460. (Pubitemid 32678277)
2. Askari B, Kanter JE, Sherrid AM, Golej DL, Bender AT, Liu J, Hsueh WA, Beavo JA, Coleman RA, Bornfeldt KE. 2007. Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma- independent mechanism in human arterial smooth muscle cells and macrophages. Diabetes 56:1143-1152. (Pubitemid 46525070)
3. Bayes-Genis A, Schwartz RS, Lewis DA, Overgaard MT, Christiansen M, Oxvig C, Ashai K, Holmes DR, Jr., Conover CA. 2001. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol 21:335-341. (Pubitemid 32199113)
4. Beyer AM, de Lange WJ, Halabi CM, Modrick ML, Keen HL, Faraci FM, Sigmund CD. 2008. Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet. Circ Res 103:654-661.
5. Bishop-Bailey D, Hla T, Warner TD. 2002. Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy. Circ Res 91:210-217. (Pubitemid 34875675)
6. Bittl JA. 1996. Advances in coronary angioplasty. N Engl J Med 335:1290-1302.
7. Chen Z, Keaney JF, Jr., Schulz E, Levison B, Shan L, Sakuma M, Zhang X, Shi C, Hazen SL, Simon DI. 2004. Decreased neointimal formation in Nox2-deficientmice reveals a direct role for NADPH oxidase in the response to arterial injury. Proc Natl Acad Sci USA 101:13014-13019. (Pubitemid 39167575)
8. Christen T, Verin V, Bochaton-Piallat M, Popowski Y, Ramaekers F, Debruyne P, Camenzind E, van Eys G, Gabbiani G. 2001. Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation 103:882-888. (Pubitemid 32163889)
9. Crowley ST, Ray CJ, Nawaz D, Majack RA, Horwitz LD. 1995. Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol 269:H1641-H1647. (Pubitemid 3005968)
10. Duan SZ, Usher MG, Mortensen RM. 2008. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ Res 102:283-294.
11. Dzau VJ, Braun-Dullaeus RC, Sedding DG. 2002. Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies. Nat Med 8:1249-1256.
12. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.Cell 83:803-812.
13. Griendling KK, FitzGerald GA. 2003. Oxidative stress and cardiovascular injury: Part II: Animals and human studies. Circulation 108:2034-2040. (Pubitemid 37337574)
14. Griendling KK, Sorescu D, Ushio-Fukai M. 2000. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86:494-501. (Pubitemid 30165039)
15. Hansmann G, de Jesus Perez VA, Alastalo TP, Alvira CM, Guignabert C, Bekker JM, Schellong S, Urashima T, Wang L, Morrell NW, Rabinovitch M. 2008. An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 118:1846-1857. (Pubitemid 351632387)
16. Heo KS, Kim DU, Ryoo S, Nam M, Baek ST, Kim L, Park SK, Myung CS, Hoe KL. 2007. PPARgamma activation abolishes LDL-induced proliferation of human aortic smooth muscle cells via SOD-mediated down-regulation of superoxide. Biochem Biophys Res Commun 359:1017-1023. (Pubitemid 46946920)
17. Hou D, Rogers PI, Toleikis PM, Hunter W, March KL. 2000. Intrapericardial paclitaxel delivery inhibits neointimal proliferation and promotes arterial enlargement after porcine coronary overstretch. Circulation 102:1575-1581. (Pubitemid 30729023)
18. Hwang J, Kleinhenz DJ, Lassegue B, Griendling KK, Dikalov S, Hart CM. 2005. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288:C899-C905. (Pubitemid 40395068)
19. 2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50:3-11.
20. Jacobson GM, Dourron HM, Liu J, Carretero OA, Reddy DJ, Andrzejewski T, Pagano PJ. 2003. Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circ Res 92:637-643. (Pubitemid 36417698)
21. Kanellakis P, Nestel P, Bobik A. 2004. Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: Suppression by the isoflavone trans-tetrahydrodaidzein. Atherosclerosis 176:63-72. (Pubitemid 39078646)
22. Kanellakis P, Pomilio G, Walker C, Husband A, Huang JL, Nestel P, Agrotis A, Bobik A. 2009. A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-kappaB signaling. Atherosclerosis 201:66-72.
23. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK. 2001. Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88:888-894. (Pubitemid 32441466)
24. Law RE, Meehan WP, Xi XP, Graf K, Wuthrich DA, Coats W, Faxon D, Hsueh WA. 1996. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J Clin Invest 98:1897-1905. (Pubitemid 26359208)
25. Law RE, Goetze S, Xi XP, Jackson S, Kawano Y, Demer L, Fishbein MC, Meehan WP, Hsueh WA. 2000. Expression and function of PPARgamma in rat and human vascular smooth muscle cells. Circulation 101:1311-1318. (Pubitemid 30158620)
26. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gammar (PPARgamma). J Biol Chem 270:12953-12956.
27. Lin S, Jin CJ, Kim M, Chung SS, Park HS, Lee IK, Lee CT, Cho YM, Lee HK, Park KS. 2006. PPARgamma gene transfer sustains apoptosis, inhibits vascular smooth muscle cell proliferation, and reduces neointima formation after balloon injury in rats. Arterioscler Thromb Vasc Biol 26:808-813. (Pubitemid 43732155)
28. Marx N, Duez H, Fruchart JC, Staels B. 2004. Peroxisome proliferator-activated receptors and atherogenesis: Regulators of gene expression in vascular cells. Circ Res 94:1168-1178. (Pubitemid 38656403)
29. McIntyre TM, Pontsler AV, Silva AR, St Hilaire A, Xu Y, Hinshaw JC, Zimmerman GA, Hama K, Aoki J, Arai H, Prestwich GD. 2003. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgammar agonist. Proc Natl Acad Sci USA 100:131-136. (Pubitemid 36078041)
30. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, Harrison DG. 2003. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 285:H2290-H2297. (Pubitemid 37443044)
31. Mueller CF, Laude K, McNally JS, Harrison DG. 2005. ATVB in focus: Redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25:274-278.
32. Muzaffar S, ShuklaN, Angelini GD, Jeremy JY. 2005. Acute hypoxia simultaneously induces the expression of gp91phox and endothelial nitric oxide synthase in the porcine pulmonary artery. Thorax 60:305-313. (Pubitemid 40522367)
33. Nakamura K, Yamagishi S, Matsui T, Yoshida T, Takenaka K, Jinnouchi Y, Yoshida Y, Ueda S, Adachi H, Imaizumi T. 2007. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation. Am J Path 170:2159-2170. (Pubitemid 47339287)
34. Ogawa D, Nomiyama T, Nakamachi T, Heywood EB, Stone JF, Berger JP, Law RE, Bruemmer D. 2006. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells. Circ Res 98:e50-e59. (Pubitemid 43755233)
35. Olefsky JM, Saltiel AR. 2000. PPAR gamma and the treatment of insulin resistance. Trends Endocrinol Metab 11:362-368. (Pubitemid 30778472)
36. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. 1997. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II. Proc Natl Acad Sci USA 94:14483-14488.
37. Phillips JW, Barringhaus KG, Sanders JM, Yang Z, Chen M, Hesselbacher S, Czarnik AC, Ley K, Nadler J, Sarembock IJ. 2003. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes. Circulation 108:1994-1999. (Pubitemid 37296545)
38. Rosenthal EA, Bohlmeyer TJ, Monnet E, MacPhail C, Robertson AD, Horwitz MA, Burchenal JE, Horwitz LD. 2001. An iron-binding exochelin prevents restenosis due to coronary artery balloon injury in a porcine model. Circulation 104:2222-2227. (Pubitemid 33043304)
39. Saward L, Zahradka P. 1996. Insulin is required for angiotensin II-mediated hypertrophy of smooth muscle cells. Mol Cell Endocrinol 122:93-100. (Pubitemid 26328862)
40. Saward L, Zahradka P. 1997. Coronary artery smooth muscle in culture: Migration of heterogeneous cell populations from vessel wall. Mol Cell Biochem 176:53-59. (Pubitemid 27491466)
41. Schopfer FJ, Lin Y, Baker PR, Cui T, Garcia-Barrio M, Zhang J, Chen K, Chen YE, Freeman BA. 2005. Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor gammar ligand. Proc Natl Acad Sci USA 102:2340-2345. (Pubitemid 40279377)
42. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA. 1994. A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331:489-495. (Pubitemid 24256751)
43. Weintraub NL. 2002. Nox response to injury. Arterioscler Thromb Vasc Biol 22:4-5.
44. Yau L, Wilson DP, Werner JP, Zahradka P. 2001. Bradykinin receptor antagonists attenuate neointimal proliferation. Am J Physiol Heart Circ Physiol 281:H1648-H1656. (Pubitemid 32948210)
45. Yeh JL, Liou SF, Chang YP, Lin SW, Liu TS, Wu BN, Chen IJ, Wu JR. 2008. Isoeugenodilol inhibits smooth muscle cell proliferation and neointimal thickening after balloon injury via inactivation of ERK1/2 pathway. J Biomed Sci 15:375-389.
46. Zalewski A, Shi Y, Johnson AG. 2002. Diverse origin of intimal cells: Smooth muscle cells, myofibroblasts, fibroblasts, and beyond? Circ Res 91:652-655.